We are very happy to announce a global exclusive license with Brigham and Women’s Hospital for the first in class convection-enhanced macroencapsulation device (ceMED) developed by Dr Jeff Karp and his team, in collaboration with the Harvard Stem Cell Institute, supported through funding by JDRF International, the leading global type 1 diabetes research and advocacy organisation. 

Read the full release:

Visualization: Randal McKenzie